CBLI : Summary for Cleveland BioLabs, Inc. - Yahoo Finance

U.S. Markets open in 6 hrs 36 mins

Cleveland BioLabs, Inc. (CBLI)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.60-0.00 (-0.09%)
At close: 4:00 PM EST
People also watch:
CYCCCLSNAVEOABIOCYTX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.60
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range1.60 - 1.63
52 Week Range1.45 - 4.04
Volume16,382
Avg. Volume44,204
Market Cap17.58M
Beta-0.81
PE Ratio (TTM)-6.15
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETFs with exposure to Cleveland BioLabs, Inc. : December 7, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Cleveland BioLabs, Inc. Here are 5 ETFs with the largest exposure to CBLI-US. Comparing the performance and risk of Cleveland BioLabs, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Cleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016
    Capital Cube24 days ago

    Cleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016

    Categories: Yahoo Finance Get free summary analysis Cleveland BioLabs, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Cleveland BioLabs, Inc. – OPKO Health, Inc., Novartis AG Sponsored ADR, Bristol-Myers Squibb Company, Cascadian Therapeutics Inc., Amgen Inc., Eli Lilly and Company and GlaxoSmithKline plc Sponsored ADR ... Read more (Read more...)

  • Marketwired25 days ago

    Cleveland BioLabs Reports Third Quarter 2016 Financial Results and Development Progress

    Cleveland BioLabs, Inc. today reported financial results and development progress for the third quarter ended September 30, 2016.